Switch to:
More From Other Websites
Ligand to Participate in Upcoming Investor Conference Mar 09 2017
New Strong Sell Stocks for March 7th Mar 07 2017
Ligand Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : LGND-US :... Mar 07 2017
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events Mar 06 2017
LIGAND PHARMACEUTICALS INC Financials Mar 03 2017
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events Mar 03 2017
Ligand Pharmaceuticals, Inc. :LGND-US: Earnings Analysis: 2016 By the Numbers : March 1, 2017 Mar 01 2017
Ligand Provides Highlights from Today’s Analyst Day Event Feb 28 2017
4:04 pm Ligand Pharma expands its license with Sermonix Pharmaceuticals to include worldwide rights... Feb 28 2017
Ligand Expands License with Sermonix to Include Worldwide Rights for Oral Lasofoxifene Feb 28 2017
6 Stocks on the Move With Unusual Volume Feb 28 2017
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Feb 28 2017
Sermonix Pharmaceuticals Secures Worldwide Rights to Oral Lasofoxifene From Ligand Pharmaceuticals,... Feb 28 2017
LIGAND PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Feb 28 2017
Ligand Pharmaceuticals, Inc. :LGND-US: Earnings Analysis: Q4, 2016 By the Numbers : February 27,... Feb 27 2017
Enrollment Completed in Ligand’s Phase 2 Trial of LGD-6972 in Type 2 Diabetes Feb 27 2017
Ligand (LGND) Q4 Earnings Down Y/Y, Revenues Miss Estimates Feb 24 2017
Edited Transcript of LGND earnings conference call or presentation 23-Feb-17 9:30pm GMT Feb 24 2017
Ligand reports 4Q loss Feb 23 2017
Ligand reports 4Q loss Feb 23 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK